JOSEPH DAVID: Open Payments
NPI 1851365936 · WARRENTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,724 in 95 payments from 17 companies in 2025. Trend: 2023 $1,436 · 2024 $1,857 · 2025 $1,724
Food & beverage: $1,710Education: $14
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $280 |
| ABBVIE INC. | 17 | $213 |
| Amgen Inc. | 12 | $203 |
| PFIZER INC. | 8 | $174 |
| Lilly USA, LLC | 8 | $165 |
| AstraZeneca Pharmaceuticals LP | 6 | $151 |
| Astellas Pharma US Inc | 6 | $137 |
| Phathom Pharmaceuticals, Inc. | 5 | $75 |
| GlaxoSmithKline, LLC. | 4 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $71 |
Products named: Ozempic, Veozah, VRAYLAR, MOUNJARO, NURTEC ODT, OTEZLA, AIRSUPRA, VOQUEZNA.
Industry payments across VA — which companies pay providers there.
